Sevim Bavbek
Overview
Explore the profile of Sevim Bavbek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akin B, Kepil Ozdemir S, Doganay Erdogan B, Gelincik A, Goksel O, Dursun A, et al.
Clin Transl Allergy
. 2025 Feb;
15(2):e70029.
PMID: 39961769
Background: Measurement of disease-specific quality of life (QOL) is crucial in evaluating the effects of disease and response to treatment. Patients' efforts to avoid the responsible medication can have a...
2.
Doganci A, Ataman S, Ozdemirel A, Seckin R, Yalcin A, Bavbek S
Turk J Med Sci
. 2024 Dec;
54(6):1310-1318.
PMID: 39734351
Background/aim: We aimed to investigate the relationship between serum antidrug antibodies (ADAbs), systemic hypersensitivity, or local injection site reactions to tumor necrosis factor (anti-TNF) drugs and to detect the role...
3.
Ozturk B, Celebi Sozener Z, Metan E, Aydin O, Bavbek S, Mungan D
Allergol Immunopathol (Madr)
. 2024 Nov;
52(6):62-71.
PMID: 39515797
Introduction: We aimed to investigate the frequency and sociodemographic and clinical distinguishing features of asthmatic patients in whom long-acting muscarinic antagonists (LAMA) were added to maintenance therapy in our clinic....
4.
Unutmaz Erkaya D, Durmaz M, Akin B, Bavbek S
Clin Transl Allergy
. 2024 Oct;
14(10):e12397.
PMID: 39434186
Background: Following the increased use of biological agents, a subset of patients experiences hypersensitivity reaction (HSR). We reported our experience with rapid drug desensitization (RDD) to nine biologics (rituximab, infliximab,...
5.
Al-Lehebi R, Al Ahmad M, Maturu V, Mesa A, Mahboub B, Garcia E, et al.
Adv Ther
. 2024 Aug;
41(11):4008-4031.
PMID: 39215767
Introduction: The Nucala Effectiveness Study (NEST) assessed the effectiveness of mepolizumab in patients with severe asthma (SA) in countries previously underrepresented in real-world studies. Methods: A multi-country, bi-directional, self-controlled, observational...
6.
Durmaz M, Unutmaz D, Demir M, Goksel O, Dursun A, Bavbek S
Allergy Asthma Immunol Res
. 2024 Mar;
16(2):142-153.
PMID: 38528382
Purpose: Taxanes can cause hypersensitivity reactions (HSRs), which pose a significant challenge in the treatment of malignancies. Patients who are eligible for rapid drug desensitization (RDD) can continue treatment; however,...
7.
Bavbek S, Kepil Ozdemir S, Bonadonna P, Atanaskovic-Markovic M, Barbaud A, Brockow K, et al.
Allergy
. 2023 Nov;
79(3):552-564.
PMID: 38013608
Proton pump inhibitors (PPIs) are invaluable therapeutic options in a variety of dyspeptic diseases. In addition to their well-known risk profile, PPI consumption is related to food and environmental allergies,...
8.
Celik G, Aydin O, Damadoglu E, Baccioglu A, Kepil Ozdemir S, Bavbek S, et al.
Thorac Res Pract
. 2023 Nov;
24(6):309-324.
PMID: 37909830
Introduction of inhaled corticosteroids (ICS) has been the cornerstone of the long-term management of asthma. ICSs either alone or in combination with long-acting beta-2 agonists have been shown to be...
9.
Colak S, Erkoc M, Sin B, Bavbek S
World Allergy Organ J
. 2023 Oct;
16(10):100822.
PMID: 37854032
No abstract available.
10.
Cerci P, Kendirlinan R, Buyukozturk S, Gelincik A, Unal D, Demir S, et al.
Allergol Immunopathol (Madr)
. 2023 Sep;
51(5):84-92.
PMID: 37695234
Background: Hypersensitivity reactions (HSRs) to nonsteroidal anti-inflammatory drugs (NSAIDs) are a significant clinical issue. Several classifications have been proposed to categorize these reactions, including the current European Academy of Allergy...